Immunic, Inc.

IMUXNASDAQHealthcareBiotechnology

$6.97- (-)1Y +787.17%

As of Oct 16, 2026 close

Market cap: $301.85M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $0.51$17.43
Volume (live): -
Avg. volume (3M): 419.13K

Immunic, Inc. (IMUX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Immunic, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy

Based on 11 unique analysts

(12 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$37.38

+436.30% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest IMUX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 8, 2026	Paul Matteis	Stifel Nicolaus	Reiterates	Buy	$25.00
Sep 11, 2026	Sam Slutsky	LifeSci Capital	Maintains	Buy	$56.00
Sep 10, 2026	Martin Fan	Wedbush	Reiterates	Buy	$45.00
Sep 10, 2026	Matthew Caufield	HC Wainwright	Reiterates	Buy	$22.00
Sep 10, 2026	Myles Minter	William Blair	Maintains	Buy	-
Sep 10, 2026	Unknown Analyst	Leerink Partners	Maintains	Buy	-
Sep 2, 2026	William Wood	B Riley	Maintains	Buy	$27.00
Sep 1, 2026	Boobalan Pachaiyappan	Roth MKM	Reiterates	Buy	$19.00 → $29.00 +10.00 (+52.6%)
Aug 13, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Aug 12, 2026	Rudy Li	Wolfe Research	Reiterates	Buy	$25.00
Aug 11, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$70.00
Aug 11, 2026	Rudy Li	Wolfe Research	Reiterates	Buy	$25.00

Paul Matteis

Stifel Nicolaus

BuyReiterates

$25.00

Oct 8

Sam Slutsky

LifeSci Capital

BuyMaintains

$56.00

Sep 11

Martin Fan

Wedbush

BuyReiterates

$45.00

Sep 10

Matthew Caufield

HC Wainwright

BuyReiterates

$22.00

Sep 10

Myles Minter

William Blair

BuyMaintains

Sep 10

Unknown Analyst

Leerink Partners

BuyMaintains

Sep 10

William Wood

B Riley

BuyMaintains

$27.00

Sep 2

Boobalan Pachaiyappan

Roth MKM

BuyReiterates

$19.00 → $29.00

Sep 1

Zacks Equity Research

BuyInitiates Coverage

Aug 13

Rudy Li

Wolfe Research

BuyReiterates

$25.00

Aug 12

Yatin Suneja

Guggenheim

BuyReiterates

$70.00

Aug 11

Rudy Li

Wolfe Research

BuyReiterates

$25.00

Aug 11

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 8, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for IMUX?

The analyst consensus rating for IMUX is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for IMUX?

The average 12-month price target for IMUX is $37.38, representing an upside of 436.3% from the Oct 16, 2026 close of $6.97.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.